IndraLab
Statements
Low-density lipoprotein inhibits CTSB. 15 / 15
|
15
sparser
"The data show that HOCl-modified LDL inactivates cathepsin B by a chloramine-dependent mechanism, most likely via oxidation of the enzyme’s critical cysteine residue, and that ascorbic and lipoic acids may be able to inhibit this potentially pro-atherogenic process by scavenging LDL-associated chloramines."